Review
Published on 07 Nov 2024
Estrogen: the forgotten player in metaflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478819
- 3,056 views
- 4 citations
Type at least 3 characters
1,752 articles
Review
Published on 06 Nov 2024
P4HA1: an important target for treating fibrosis related diseases and cancer
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493420
- 2,804 views
Review
Published on 05 Nov 2024
The impact of diabetes mellitus on tendon pathology: a review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491633
- 2,404 views
- 1 citation
Editorial
Published on 31 Oct 2024
Editorial: Chronic pain: what is the mechanism?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496510
- 773 views
Case Report
Published on 30 Oct 2024
Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472667
- 1,722 views
Review
Published on 29 Oct 2024
JAK inhibitors: an evidence-based choice of the most appropriate molecule
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494901
- 3,685 views
- 1 citation
Editorial
Published on 28 Oct 2024
Editorial: Epigenetics of inflammatory reactions and pharmacological modulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505196
- 713 views
- 1 citation
Review
Published on 25 Oct 2024
Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488036
- 1,987 views
- 2 citations
Review
Published on 23 Oct 2024
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491400
- 2,141 views
- 1 citation
Mini Review
Published on 21 Oct 2024
Research progress of knee fibrosis after anterior cruciate ligament reconstruction
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493155
- 1,792 views
- 1 citation
Clinical Trial
Published on 21 Oct 2024
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445708
- 1,284 views
Review
Published on 18 Oct 2024
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477680
- 2,048 views
- 1 citation
Original Research
Published on 08 Oct 2024
Causal links between circulatory inflammatory cytokines and risk of digestive polyps: a Mendelian randomization analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405503
- 1,792 views
Systematic Review
Published on 25 Sep 2024
Systematic review of Janus kinases inhibitors for rheumatoid arthritis: methodology, reporting, and quality of evidence evaluation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1459511
- 1,482 views
Mini Review
Published on 20 Sep 2024
Inflammation in a ferroptotic environment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1474285
- 3,274 views
- 5 citations
Original Research
Published on 20 Sep 2024
Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1479503
- 1,687 views
- 1 citation